|
ATCC
l tarentolae strain L Tarentolae Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/l tarentolae strain/product/ATCC Average 94 stars, based on 1 article reviews
l tarentolae strain - by Bioz Stars,
2026-03
94/100 stars
|
Buy from Supplier |
|
ATCC
l tarentolae tar ii ![]() L Tarentolae Tar Ii, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/l tarentolae tar ii/product/ATCC Average 93 stars, based on 1 article reviews
l tarentolae tar ii - by Bioz Stars,
2026-03
93/100 stars
|
Buy from Supplier |
|
ATCC
l tarentolae ![]() L Tarentolae, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/l tarentolae/product/ATCC Average 93 stars, based on 1 article reviews
l tarentolae - by Bioz Stars,
2026-03
93/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Iranian Journal of Parasitology
Article Title: Immunogenicity and Efficacy of Live L. tarentolae Expressing KMP11-NTGP96-GFP Fusion as a Vaccine Candidate against Experimental Visceral Leishmaniasis Caused by L. infantum
doi:
Figure Lengend Snippet: Electrophoresis of the amplified KMP-11, NT-GP96 and KMP11-NTGP96 fusion genes in PCR reaction with using: A. recombinant L. tarentolae DNA as the template and genes specific primers that Lane1: 1kb DNA ladder; Lanes 2, 3, 4: expanded bands of KMP-11, NT-GP96 and KMP11-NTGP96 fusion genes (approximately 279 bp, 1014 bp and 1293 bp respectively) ;and B. recombinant parasite cDNA as the template and genes specific primers that Lanes 1, 2, 3: expanded bands of KMP-11, NT-GP96 and KMP11-NTGP96 fusion genes (approximately 279 bp, 1014 bp and 1293 bp respectively); lane 4: wild L. tarentolae as the negative control; Lane5: 1kb DNA ladder
Article Snippet: The
Techniques: Electrophoresis, Amplification, Recombinant, Negative Control
Journal: Iranian Journal of Parasitology
Article Title: Immunogenicity and Efficacy of Live L. tarentolae Expressing KMP11-NTGP96-GFP Fusion as a Vaccine Candidate against Experimental Visceral Leishmaniasis Caused by L. infantum
doi:
Figure Lengend Snippet: Electrophoresis of the amplified fragments (1 Kb) of specific targeting of the expression cassette into the ssu locus in PCR reaction with using recombinant L. tarentolae DNA as the template and vector specific primers on 1.2 % (w/v) agarose gel. Lane1: 1kb DNA ladder; Lanes 2: expanded bands of 1Kb
Article Snippet: The
Techniques: Electrophoresis, Amplification, Expressing, Recombinant, Plasmid Preparation, Agarose Gel Electrophoresis
Journal: Iranian Journal of Parasitology
Article Title: Immunogenicity and Efficacy of Live L. tarentolae Expressing KMP11-NTGP96-GFP Fusion as a Vaccine Candidate against Experimental Visceral Leishmaniasis Caused by L. infantum
doi:
Figure Lengend Snippet: Expression of the fusion gene by L. tarentolae . (A) Western blot analysis for evaluating expression of the KMP11-NTGP96-GFP fusion protein. (B) Expression of EGFP by recombinant L. tarentolae promastigotes.(C)Percentage of the EGFP positive population in L. tarentolae promastigotes transfected with either pLEXSY-KMP11-NTGP96-GFP (I) or pLEXSY-KMP11-GFP (II) that shown in green lines in comparison to wild type parasite that shown in red lines as determined by flowcytometry
Article Snippet: The
Techniques: Expressing, Western Blot, Recombinant, Transfection, Comparison
Journal: Iranian Journal of Parasitology
Article Title: Immunogenicity and Efficacy of Live L. tarentolae Expressing KMP11-NTGP96-GFP Fusion as a Vaccine Candidate against Experimental Visceral Leishmaniasis Caused by L. infantum
doi:
Figure Lengend Snippet: Analysis of the specific cellular and humoral response factors in vaccinated and control groups before and after challenge. (I) Cytokine production by splenocytes in vaccinated and control groups. A: IFN-γ production by splenocytes in vaccinated and control groups after stimulation with F/T L. tarentolae -KMP11-NTGP96-GFP (* P < 0.05 compared to PBS); B: IL-4-γ production by splenocytes in vaccinated and control groups after stimulation with F/T L. tarentolae -KMP11-NTGP96-GFP (* P < 0.05 compared to PBS); C: IFN-γ/IL-4 ratio in vaccinated and control groups after stimulation with F/T L. tarentolae -KMP11-NTGP96-GFP (* P < 0.05 compared to PBS). (II)Analysis of the specific IgG isotypes in vaccinated and control groups. A: Specific IgG2a antibody isotypes detected by ELISA in the sera of mice in vaccinated and control groups ( P < 0.01 compared to PBS); Bˊ: Specific IgG1 antibody isotypes detected by ELISA in the sera of mice in vaccinated and control groups (* P < 0.01 compared to PBS); Cˊ: IgG2a/IgG1 ratio in vaccinated and control groups before and 4 weeks after challenge (* P < 0.01 compared to PBS).
Article Snippet: The
Techniques: Control, Enzyme-linked Immunosorbent Assay